EGS Beteiligungen AG exercised its right to convert also the second of the two convertible bonds issued in December 2020 with a coupon of 1.15% and a nominal value of CHF 40m into shares of Siegfried Holding AG. EGS Beteiligungen AG will receive 48'054 shares and as a result will increase its stake in Siegfried from 6.2% to about 7.2% registered sh [ … ]

Siegfried AG / Key word(s): Miscellaneous Siegfried opens new quality control lab in Minden 30.08.2024 / 06:30 CET/CEST Siegfried inaugurated its new state-of-the-art quality control lab in Minden. The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale produc [ … ]

In the first half of 2024, Siegfried (SIX: SFZN) continued its journey of profitable growth. Significant progress has been made in the implementation of the corporate strategy EVOLVE which is geared towards long-term profitable growth in core areas and beyond. Net sales amounted to CHF 619.9 million, an increase of 3.5% in local currencies (2.1% i [ … ]

The Board of Directors of Siegfried Holding AG has appointed Marcel Imwinkelried as the new CEO with effect as of September 1, 2024. He will succeed Reto Suter, who has been leading the Siegfried Group as CEO ad interim since May 1, 2024, and will now focus again on his role as CFO. Marcel Imwinkelried (1967) joined the Siegfried Group in January 2 [ … ]

Siegfried AG / Key word(s): Acquisition Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) 02.07.2024 / 06:30 CET/CEST Siegfried (SIX: SFZN) has completed the acquisition of an early-phase CDMO site in Grafton, Wisconsin (US) from Curia Global, strengthening Siegfried's customer offering for  [ … ]

  EGS Beteiligungen AG exercised its right to convert one of the convertible bonds issued in December 2020 with a coupon of 0.650% and a nominal value of CHF 40m into shares. EGS Beteiligungen will receive 51'899 shares of Siegfried Holding AG and as a result will increase its stake in Siegfried from 5.0% to about 6.2% registered shares (about 7.2 [ … ]

Siegfried to acquire a CDMO specialized in early-phase development and manufacturing services in Grafton, Wisconsin (US) The new site is set to strengthen Siegfried's customer offering for Drug Substances in terms of capabilities and geography Siegfried will further develop the site into its North American Siegfried Acceleration Hub for early-pha [ … ]